Image

Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis Guidelines

Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis Guidelines

Recruiting
All
Phase N/A

Powered by AI

Overview

This study evaluates a concept called 'Teaching the Teachers' and whether it is helpful in disseminating guidelines on the national and international levels. "Teaching the Teachers" involves teaching the guidelines to experts who later teach the same guidelines to other radiologists, trainees, and physicians to assume the teacher's role and disseminate the guidelines and so on.

Description

PRIMARY OBJECTIVES:

I. Evaluate the magnitude of teaching of hepatocellular carcinoma (HCC) diagnostic guidelines after applying "Teaching the Teachers" concept.

II. Assess the effect of "Teaching the Teachers" concept on application of guidelines in clinical practice.

OUTLINE

Participants complete surveys immediately after completion of a HCC diagnostic guideline webinar, monthly thereafter, and again at 6 months.

Eligibility

Inclusion Criteria:

  • Physicians who finished radiology residency
  • Radiologists with current or completed specialized training in abdominal imaging
  • Radiologists with expertise in liver imaging with no minimum number of years of experience
  • Radiologists working in academic, community, and governmental practices
  • Radiologists with current practice in any country around the globe
  • Radiologists with and without previous knowledge of HCC diagnosis guidelines (Liver Imaging Reporting and Data System [LI-RADS])
  • Radiologists with interest in education and/or teaching

Exclusion Criteria:

  • Physicians with no formal training in radiology
  • Radiologists with no expertise in abdominal/liver imaging
  • Current radiology residents
  • Radiologists with no interest in education and/or teaching

Study details
    Hepatocellular Carcinoma

NCT05143619

M.D. Anderson Cancer Center

6 May 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.